References
- Witorsh P, Utz J P. North American blastomycosis: A study of 40 patients. Medicine 1968; 47: 169–200
- Carman W F, Frean J A, Crewe-Brown H H, Culligan G A, Young C N. Blastomycosis in Africa. Mycopathologia 1989; 107: 25–32
- Busey J F. Blastomycosis: A comparative study of 2-hydroxy stilbamidine and amphotericin B therapy. Am Rev Respir Dis 1972; 105: 812–8
- Parker J D, Doto I L, Tosh F E. A decade of experience with blastomycosis and its treatment with amphoericin B. Am Rev Respir Dis 1969; 99: 895–902
- Abernathy R S. Amphotericin B therapy of north amerícan blastomycosis. Antimicrob Agents Chemother 1967; 3: 208–11
- Bradsher R W, Rice D C, Abernathy R S. Ketoconazole therapy for endemic blastomycosis. Ann Intern Med 1985; 103: 872–9
- McManus E J, Jones M. The use of ketoconazole in the treatment of blastomycosis. Am Rev Respir Dis 1986; 133: 141–3
- Arathoon E G, Brunner E, Stevens D A. Efficacy of itraconazole in blastomycosis in a murine model and comparison with kotoconazole. Mycoses 1989; 32(suppl. 1)109–12
- Stevens D A, Brunner E, McEwen J G, Perlman A M. Comparison of fluconazole and ketoconazole in experimental murine blastomycosis. Rev Inf Dis 1990; 12: 5304–6
- Kafman L, Standard P G. Specific and rapid identification of medically important fungi by exoantigen detection. Ann Rev Microbiol 1987; 41: 209–25
- Rippon J W. Medical mycology, the pathogenic fungi and the pathogenic actinomycetes. W.B. Saunders, Philadelphia 1988
- Roos L K, Bryan J P, Maggio W N, Jane J A, Sheld W M. Intracranial blastomycoma. Medicine 1987; 66: 224–35
- Brammer K W, Tarbit M H. Revue de la pharmacocinetique du fluconazole (UK 49858) chez les animaux de laboratoire et chez l'homme. Recent trends in the discovery, development and evaluation of antifungal agents, R A Fromtling. JR Prous Science Publisher S.A., London 1987